The PennZone

  • Home
  • Health
  • Non-profit
  • Business
  • Services
  • Technology
  • Sports
  • Construction
  • Books

Symplast Pioneers Live Telehealth in Plastic Surgery with New 'Video Visit' Virtual Consultations
The PennZone/10035197

Trending...
  • HBZBZL Unveils "Intelligent Ecosystem" Strategy: Integrating AI Analytics with Web3 Incubation
  • A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
  • eJoule Inc Participates in Silicon Dragon CES 2026
Introducing Video Visit by Symplast Telehealth reimagined for aesthetics
HIPAA Secure, Live Video Streaming Now Available for all Symplast Users via the Symplast App

FORT LAUDERDALE, Fla. - PennZone -- Symplast, the #1 mobile EHR/PM for plastic surgery and med spas, announced today the release of a new live-video telemedicine feature: Video Visit. Symplast's 3,500+ clinical users across the country can now conduct virtual consultations and other types of virtual appointments in a HIPAA secure, encrypted manner with their patients. This latest enhancement to the Symplast mobile ecosystem is included at no additional cost to every Symplast customer, delivering the convenience of virtual care to a patient's iOS or Android mobile device.

VIDEO VISIT FUNCTIONALITY
  • Ability to conduct live, HIPAA secure video appointments between the Symplast Practice App and the Symplast Patient App.
  • Fully integrated and ready to use for all Symplast users - no additional fees or charges.
  • Capture screenshots during the consultation that are automatically added into the patient's file.
  • Automated appointment reminder SMS text prompts patient to download Patient App for a Video Visit.
  • Updated artificially intelligent Practice Flow room manager that includes Video Visit waiting area and room.

THE DREAM OF VIDEO TELEHEALTH IS NOW A REALITY FOR AESTHETICS

More on The PennZone
  • Dugan Air Donates $10,000 to Indian Creek Schools
  • Robert DeMaio, Phinge Founder & CEO, Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
  • The 22% Tax Reality: Finland's New Gambling Law Creates a "Fiscal Trap" for Grey Market Casino Players
  • Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes

Symplast Founder Dr. Shashi Kusuma spoke to the importance telehealth has played since Symplast's origins: "Symplast was founded on the principles of patient engagement, mobility and cutting-edge multimedia. Telemedicine and telehealth have been at the core of Symplast's mission and vision from day one.

We're very excited to introduce such a powerful feature into the plastic surgery workflow. There is a definite need for live video conferencing. Unfortunately, most practices are forced to resort to using Skype or Facetime to offer virtual care. This, obviously, is far from ideal due to HIPAA violations. By having a seamless, integrated telehealth offering interwoven into the clinical workflows throughout our Symplast platform, our users can more easily incorporate this advantageous offering into their business model right away."

SEAMLESS INTEGRATION INTO CLINICAL WORKFLOWS
Symplast CEO/CTO Facundo Formica: "From a product development standpoint, our team understood that there were two critical capabilities our telehealth offering must include:
  • Actual streaming of live video, in order to replace the non-HIPAA secure alternatives of Facetime and Skype that so many practices resort to.
  • End-to-end integration of the Video Visit within the overall Symplast workflows.
From a user experience standpoint, we worked diligently to ensure that our Video Visit would blend in seamlessly to the workflows of every user in the practice, not just the doctor. From the front desk scheduling the appointment, to the coordinator or staff member updating the virtual appointment's status, to the ability for the doctor to capture screenshots during the Video Visit that are stored directly into the patient's Multimedia Manager. I'm proud to say that our new Video Visit has exceeded all of our expectations."

More on The PennZone
  • Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion
  • Golden Paper Launches a New Chapter in Its Americas Strategy- EXPOPRINT Latin America 2026 in Brazil
  • UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
  • TheOneLofi2: New Home for Chill Lo-Fi Hip Hop Beats Launches on YouTube
  • eJoule Inc Participates in Silicon Dragon CES 2026

For more information on the brand new Video Visit virtual care feature by Symplast, please visit https://symplast.com/video-visit or contact us at hello@symplast.com or (844)-SYMPLAST.

ABOUT SYMPLAST
Founded by plastic surgeons in 2013, Symplast is the #1 Mobile EHR/PM for plastic surgery. Symplast delivers a HIPAA secure cloud platform to over 3,500 aesthetic users across the country. Symplast's user-friendly, end-to-end solution optimizes aesthetic practices and medspas from anywhere in the world.

From front desk automation to clinical intelligence, Symplast eliminates inefficiencies with a comprehensive ecosystem that includes: EHR, PM, Virtual Consultations, Patient Engagement, e-Prescription, Financial Intelligence, POS, Analytics, Automated Appointment Reminders, HIPAA Secure Texting, and more. Symplast is also the first ANN Optimized Platform. Visit symplast.com or email hello@symplast.com to learn more.

Media Contact
Ronald Khadaran
SVP, Marketing
Symplast
***@symplast.com


Source: Symplast
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
  • Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
  • Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
  • UK Financial Ltd Launches U.S. Operations Following Delaware Approval
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
  • Top Tips for Hiring HVAC Contractors in Philadelphia
  • Harry Hayman of Feed Philly Coalition Proudly Supports Sharing Excess' Holiday Food Rescue — Bri
  • Virtual Pizza Academy Announces the Return of Two Acclaimed Live Classes in 2026:
  • Teresa James & The Rhythm Tramps announce their new album and debut on MoMojo Records, 'Bad at Being Good'
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
  • Beycome Closes $2.5M Seed Round Led by InsurTech Fund
  • VIP Vacations Invited to Travel Weekly's Annual Readers Choice Awards
  • Tru by Hilton Columbia South Opens to Guests
  • Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
  • "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
  • Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots

Popular on PennZone

  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 168
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 149
  • Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
  • New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • Twin Flame Visions Disrupts the Industry With Record Ad Performance and Rapid User Growth
  • Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
  • From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog

Similar on PennZone

  • Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
  • Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
  • OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
  • Robert DeMaio, Phinge Founder & CEO, Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
  • The 22% Tax Reality: Finland's New Gambling Law Creates a "Fiscal Trap" for Grey Market Casino Players
  • Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
  • eJoule Inc Participates in Silicon Dragon CES 2026
  • HBZBZL Unveils "Intelligent Ecosystem" Strategy: Integrating AI Analytics with Web3 Incubation
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us